Business Standard

Thursday, December 26, 2024 | 03:43 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19: India clears first list of HCQ requests; US to get 3.5 mn tablets

The government on Friday said that there was enough stock of HCQ in the country and it was taking all steps to ensure that there was no shortage of the drug in the domestic market.

Laboratory technicians, seen behind a blue-tinted window, work on testing patient samples for the new coronavirus that causes COVID-19, at the Pathologists Lancet Kenya laboratory in Nairobi, Kenya. Photo: PTI
Premium

Hydroxychloroquine has been on demand ever since it was named as a possible treatment for Covid-19.

BS Web TeamAgencies
India has shipped the first list of hydroxychloroquine drug to 13 countries — the US, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Sri Lanka, Afghanistan, Maldives and Bangladesh — according to sources. Hydroxychloroquine (HCQ), best known for treating malaria and lupus erythematosus, is in great demand globally these days as it is believed to be a possible treatment for Covid-19, though it has yet to be proved through scientific evidence.  

Which country gets how much

According to sources, the US had asked for 4.8 million HCQ tablets, of which

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in